Previous Page  53 / 56 Next Page
Information
Show Menu
Previous Page 53 / 56 Next Page
Page Background

Pembro+trastuzumab+

capecitabina+oxaliplatino

Juriy Janjigian Y et al ASCO-GI 2019; abst 62